@ARTICLE{
author={Schadendorf Dirk,...,Kandolf-Sekulovic Lidija O,...,Mijuskovic Zeljko P,...,(broj koautora 20)},
year={2024},
title={Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial},
journal={ANNALS OF ONCOLOGY},
volume={35},
number={},
pages={1235-1236},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Asher Nethanel,Mohr Peter,Ellebaek Eva,Bender Marc,Mangana Joanna,Kandolf Lidija O,Gavrilova Iva,Ascierto Paolo Antonio,Gogas Helen,Rutkowski Piotr,Schadendorf Dirk,Bastholt Lars,Weichenthal Michael},
year={2024},
title={Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={42},
number={16},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Schadendorf Dirk,...,Kandolf-Sekulovic Lidija O,...,Mijuskovic Zeljko P,...,(broj koautora 20)},
year={2022},
title={Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={40},
number={16},
pages={-},
document_type={Meeting Abstract},
}